Field Trip Health Ltd.

Fichier Type Date
December 2020 Monthly Progress Report (Form 7) Rapport d'activité mensuel 05/01/2021
Form 11 - December Option Grants Proposition d'options d'achat 31/12/2020
Form 5 - Quarterly Listing Statement (Second Quarter 2020) Déclaration d'inscription trimestrielle 30/11/2020
Form 7 - Monthly Progress Report Oct 2020 Rapport d'activité mensuel 06/11/2020
Form 11 - Mo Rahim Option Amendment Proposition d'options d'achat 03/11/2020
Form 11 - October Grants Proposition d'options d'achat 02/11/2020
Stock Option Plan Autre 08/10/2020
Notice of Intent Autre 08/10/2020
Notice of Change of Corporate Structure Autre 08/10/2020

Field Trip is a global leader in the development and delivery of psychedelic therapies.

December 2020 Monthly Progress Report (Form 7)

Form 11 - December Option Grants

Form 5 - Quarterly Listing Statement (Second Quarter 2020)

Form 7 - Monthly Progress Report Oct 2020

Form 11 - Mo Rahim Option Amendment

Français

Field Trip Health Ltd. Warrants

Fichier Type Date
December 2020 Monthly Progress Report (Form 7) Rapport d'activité mensuel 05/01/2021
Form 11 - December Option Grants Proposition d'options d'achat 31/12/2020
Form 5 - Quarterly Listing Statement (Second Quarter 2020) Déclaration d'inscription trimestrielle 30/11/2020
Form 7 - Monthly Progress Report Oct 2020 Rapport d'activité mensuel 06/11/2020
Form 11 - Mo Rahim Option Amendment Proposition d'options d'achat 03/11/2020
Form 11 - October Grants Proposition d'options d'achat 02/11/2020
Stock Option Plan Autre 08/10/2020
Notice of Intent Autre 08/10/2020
Notice of Change of Corporate Structure Autre 08/10/2020

Field Trip is a global leader in the development and delivery of psychedelic therapies.

December 2020 Monthly Progress Report (Form 7)

Form 11 - December Option Grants

Form 5 - Quarterly Listing Statement (Second Quarter 2020)

Form 7 - Monthly Progress Report Oct 2020

Form 11 - Mo Rahim Option Amendment

Anglais

Tryp Therapeutics Inc.

The Company is a pharmaceutical company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The Company intends to do this through the development of compounds with known activity and/or safety profiles. The Company’s lead program is designed to address neurological disorders through the therapeutic dosing of synthetic psilocybin.

Anglais

EYEFI Group Technologies Inc.

EYEFI Group Technologies Inc. is a software and electronics engineering company that has developed, patented and commercialized an innovative spatial technology called EYEfi SPARC, that turns any sensor, camera or smartphone device (fixed, mobile, airborne, portable or handheld) into a geo-pointing system. It has also developed an Industrial Internet of Things (IIoT) sensor and cloud application.

Anglais

Newscope Capital Corporation

La société se concentre sur la réutilisation de médicaments grâce à l'intelligence artificielle. La plate-forme d’intelligence artificielle de réutilisation des médicaments de la société combine des processus multicouches permettant d’intégrer des millions de points de données et d’effectuer un apprentissage automatique pour découvrir de nouvelles utilisations des médicaments.

Français

Newscope Capital Corporation

Pharmather is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals.  Pharmather was founded with a particular focus on repurposing psychedelic pharmaceuticals, such as ketamine and psilocybin, for FDA approval to treat disorders of the brain and nervous system.

Anglais